S. Rosario

发表

EZH2 inhibition re-sensitizes multidrug resistant B-cell lymphomas to etoposide mediated apoptosis

M. Smonskey, E. Lasorsa, S. Rosario, 2016, Oncoscience.

Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas

D. Smiraglia, K. Eng, S. Rosario, 2018, Nature Communications.

Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas

D. Smiraglia, K. Eng, S. Rosario, 2018, bioRxiv.

Whole-Genome Sequencing Identifies PPARGC1A as a Putative Modifier of Cancer Risk in BRCA1/2 Mutation Carriers

Q. Hu, Qianqian Zhu, T. Conrads, 2022, Cancers.

Mitochondrial protection impairs BET bromodomain inhibitor-mediated cell death and provides rationale for combination therapeutic strategies

E. Lasorsa, S. Rosario, J. Kirk, 2015, Cell Death and Disease.

Reduced NCOR2 expression accelerates androgen deprivation therapy failure in prostate cancer

D. Smiraglia, S. Rosario, J. Kirk, 2020, bioRxiv.

The Challenges of Modeling Drug Resistance to Antiangiogenic Therapy.

S. Rosario, R. Brekken, J. Ebos, 2016, Current drug targets.

The Differential Paracrine Role of the Endothelium in Prostate Cancer Cells

D. Smiraglia, S. Rosario, Julio D Amigo, 2022, Cancers.

Addition of losartan to FOLFORINOX and chemoradiation downregulates pro-invasion and immunosuppression-associated genes in locally advanced pancreatic cancer

Jeffrey, Y. Boucher, M. Mino‐Kenudson, 2022, medRxiv.

Altered acetyl-CoA metabolism presents a new potential immunotherapy target in the obese lung microenvironment

S. Patnaik, S. Rosario, S. Yendamuri, 2022, Cancer & Metabolism.

BORIS Expression in Ovarian Cancer Precursor Cells Alters the CTCF Cistrome and Enhances Invasiveness through GALNT14

Song Liu, Victor V Lobanenkov, D. Loukinov, 2019, Molecular Cancer Research.

Hypoxic activation of PFKFB4 in breast tumor microenvironment shapes metabolic and cellular plasticity to accentuate metastatic competence

W. Bshara, M. Seshadri, S. Rosario, 2022, Cell reports.

Pharmacological polyamine catabolism upregulation with methionine salvage pathway inhibition as an effective prostate cancer therapy

Bryan M. Gillard, Michael Moser, E. Karasik, 2020, Nature Communications.

Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance

Henry W. Long, M. Loda, B. Xu, 2017, Science.

TOP2A and EZH2 Provide Early Detection of an Aggressive Prostate Cancer Subgroup

F. Feng, R. Karnes, D. Spratt, 2017, Clinical Cancer Research.

The miR-96 and RARγ signaling axis governs androgen signaling and prostate cancer progression

Lara E Sucheston-Campbell, Abbas A. Rizvi, Lara E. Sucheston-Campbell, 2018, Oncogene.

The miR-96/RARγ signaling axis governs androgen signaling and prostate cancer progression

Lara E Sucheston-Campbell, Abbas A. Rizvi, Lara E. Sucheston-Campbell, 2017, bioRxiv.

Pan-cancer molecular analysis of the RB tumor suppressor pathway

D. Smiraglia, S. Rosario, E. Knudsen, 2020, Communications Biology.

Inhibition of the aryl hydrocarbon receptor/polyamine biosynthesis axis suppresses multiple myeloma

P. L. Bergsagel, E. Kandel, D. Smiraglia, 2018, The Journal of clinical investigation.

Dietary folate levels alter the kinetics and molecular mechanism of prostate cancer recurrence in the CWR22 model

Bryan M. Gillard, E. Karasik, B. Foster, 2017, Oncotarget.

Racial differences in androgen metabolism and receptor signaling in prostate cancer

R. Kittles, Jianmin Wang, D. Smiraglia, 2021, bioRxiv.

Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cells

Song Liu, J. Wrana, Jiaoti Huang, 2023, bioRxiv.

Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses

P. Danaher, C. Morrison, Song Liu, 2022, Science Translational Medicine.

Pan-cancer molecular analysis of the RB tumor suppressor pathway

D. Smiraglia, S. Rosario, E. Knudsen, 2020, Communications Biology.

Combined BRCA2 and MAGEC3 Expression Predict Outcome in Advanced Ovarian Cancers

K. Eng, J. Ohm, S. Rosario, 2022, medRxiv.

HotSPOT: A Computational Tool to Design Targeted Sequencing Panels to Assess Early Photocarcinogenesis

B. Foster, Lei Wei, S. Rosario, 2023, Cancers.

Addition of losartan to FOLFIRINOX and chemoradiation reduces immunosuppression-associated genes, Tregs and FOXP3+ cancer cells in locally advanced pancreatic cancer.

Jeffrey W. Clark, R. Jain, Y. Boucher, 2023, Clinical cancer research : an official journal of the American Association for Cancer Research.

Deoxyhypusine synthase is required for the translational regulation of pancreatic beta cell maturation

Teresa L. Mastracci, Leah R. Padgett, S. Rosario, 2023, bioRxiv.

Metabolic Dysregulation Explains the Diverse Impacts of Obesity in Males and Females with Gastrointestinal Cancers

Song Liu, M. Churchman, S. Rosario, 2023, International journal of molecular sciences.

Deoxyhypusine synthase mutations alter the post-translational modification of eukaryotic initiation factor 5A resulting in impaired human and mouse neural homeostasis

Teresa L. Mastracci, Leah R. Padgett, S. Rosario, 2023, HGG advances.

BiTE secretion by adoptively transferred stem-like T cells improves FRα+ ovarian cancer control

K. Odunsi, S. Rosario, M. Long, 2023, Journal for ImmunoTherapy of Cancer.

Immunoprofiling bronchoalveolar lavage cells reveals multifaceted smoking-associated immune dysfunction

S. Rosario, S. Yendamuri, M. Reid, 2023, ERJ Open Research.

Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cells.

Song Liu, J. Wrana, Jiaoti Huang, 2024, Cell Stem Cell.